{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:22:55Z","timestamp":1790817775088,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002507","name":"Kangwon National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2021R1A2C2008235"],"award-info":[{"award-number":["NRF- 2021R1A2C2008235"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00517986"],"award-info":[{"award-number":["RS-2025-00517986"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004083","name":"Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-R1A4A1031574"],"award-info":[{"award-number":["NRF-R1A4A1031574"]}],"id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpddr.2025.100613","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:52:44Z","timestamp":1758070364000},"page":"100613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dual-targeting proteasome inhibitor ONX-0914 demonstrates potent antiplasmodial activity for malaria treatment"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5615-5670","authenticated-orcid":false,"given":"Nguyen","family":"Van Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuyet-Kha","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-6211","authenticated-orcid":false,"given":"Nguyen Sy","family":"Thau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Thanh Hang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bazgha","family":"Sanaullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch","family":"Venkataramaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hun","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Joo","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hwan","family":"No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1962-7199","authenticated-orcid":false,"given":"Eun-Taek","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2025.100613_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.44.1.88-96.2000","article-title":"In Vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum","volume":"44","author":"Akompong","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100613_bib2","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","article-title":"Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events","volume":"17","author":"Arastu-Kapur","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpddr.2025.100613_bib3","series-title":"Animal Cell Culture Guide","year":"2024"},{"key":"10.1016\/j.ijpddr.2025.100613_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd3321","article-title":"Ubiquitin-like protein conjugation and the ubiquitin\u2013proteasome system as drug targets","volume":"10","author":"Bedford","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2025.100613_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102310","article-title":"Ubiquitin proteasome system in immune regulation and therapeutics","volume":"67","author":"Bhat","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2025.100613_bib6","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2025.100613_bib7","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple myeloma","volume":"10","author":"Bross","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpddr.2025.100613_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1556\/1886.2017.00025","article-title":"Low neurotoxicity of ONX-0914 supports the idea of specific immunoproteasome inhibition as a side-effect-limiting, therapeutic strategy","volume":"7","author":"Brzezinski","year":"2017","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"10.1016\/j.ijpddr.2025.100613_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100613_bib10","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","article-title":"The ubiquitin\u2013proteasome pathway: on protein death and cell life","volume":"17","author":"Ciechanover","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ijpddr.2025.100613_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12936-015-0729-9","article-title":"Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials","volume":"14","author":"Combrinck","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100613_bib12","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/AAC.00088-09","article-title":"The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity","volume":"53","author":"Czesny","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2025.100613_bib13","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1182\/blood-2010-04-276626","article-title":"A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma","volume":"116","author":"Chauhan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ijpddr.2025.100613_bib14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3892\/ol.2020.11678","article-title":"Effect of bortezomib on proliferation and apoptosis of myeloma cells by activating Wnt\/\u03b2-catenin signaling pathway","volume":"20","author":"Dai","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijpddr.2025.100613_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance","volume":"13","author":"Dogovski","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijpddr.2025.100613_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/acsbiomedchemau.2c00063","article-title":"Targeted protein degradation for infectious diseases: from basic biology to drug discovery","volume":"3","author":"Espinoza-Ch\u00e1vez","year":"2023","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.ijpddr.2025.100613_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2025.100613_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/376596","article-title":"Malaria is related to decreased nutritional status among Male adolescents and adults in the setting of intense perennial transmission","volume":"188","author":"Friedman","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100613_bib19","series-title":"Fusion Software User and Service Manual","year":"2018"},{"key":"10.1016\/j.ijpddr.2025.100613_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1441352","article-title":"Ubiquitin-proteasome system in Plasmodium: a potential antimalarial target to overcome resistance - a systematic review","volume":"11","author":"Gon\u00e7alves","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.ijpddr.2025.100613_bib21","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.3390\/ijms20215326","article-title":"Chemical patterns of proteasome inhibitors: lessons learned from two decades of drug design","volume":"20","author":"Guedes","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpddr.2025.100613_bib22","doi-asserted-by":"crossref","first-page":"8399","DOI":"10.1038\/s41598-018-26532-z","article-title":"Ubiquitin proteasome pathway proteins as potential drug targets in parasite Trypanosoma cruzi","volume":"8","author":"Gupta","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2025.100613_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/pim.12277","article-title":"Investigating proteasome inhibitors as potential adjunct therapies for experimental cerebral malaria","volume":"37","author":"Howland","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ijpddr.2025.100613_bib24","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1038\/s41467-023-44077-2","article-title":"Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors","volume":"14","author":"Hsu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2025.100613_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2011.12.030","article-title":"Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity","volume":"148","author":"Huber","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijpddr.2025.100613_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.str.2014.11.019","article-title":"Bortezomib-resistant mutant proteasomes: structural and biochemical evaluation with carfilzomib and ONX 0914","volume":"23","author":"Huber","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.ijpddr.2025.100613_bib27","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2025.100613_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijpddr.2018.08.001","article-title":"Validation of Babesia proteasome as a drug target","volume":"8","author":"Jalovecka","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2025.100613_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90451-9","article-title":"Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL-AF4 fusion protein","volume":"11","author":"Jenkins","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2025.100613_bib30","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1021\/acs.jmedchem.8b01201","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100613_bib31","doi-asserted-by":"crossref","first-page":"E6863","DOI":"10.1073\/pnas.1806109115","article-title":"Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance","volume":"115","author":"Kirkman","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ijpddr.2025.100613_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024523","article-title":"Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial","volume":"9","author":"Kohler","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijpddr.2025.100613_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00003088-199630040-00002","article-title":"Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications","volume":"30","author":"Krishna","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpddr.2025.100613_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100613_bib35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.chembiol.2024.07.001","article-title":"Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria","volume":"31","author":"Lawong","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ijpddr.2025.100613_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature16936","article-title":"Structure- and function-based design of Plasmodium-selective proteasome inhibitors","volume":"530","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2025.100613_bib37","article-title":"Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa","volume":"3","author":"Lucy","year":"2018","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.ijpddr.2025.100613_bib38","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1021\/acsinfecdis.9b00216","article-title":"Identification of small molecules disrupting the ubiquitin proteasome system in malaria","volume":"5","author":"Mata-Cantero","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100613_bib39","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1021\/acsinfecdis.1c00110","article-title":"High throughput screening to identify selective and Nonpeptidomimetic proteasome inhibitors as antimalarials","volume":"7","author":"Mata-Cantero","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100613_bib40","series-title":"Target Product Profiles (TPPs) and Target Candidate Profiles (TCPs) for Malaria Medicines","year":"2018"},{"key":"10.1016\/j.ijpddr.2025.100613_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpddr.2025.100613_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12936-018-2420-4","article-title":"In vitro invasion inhibition assay using antibodies against Plasmodium knowlesi duffy binding protein alpha and apical membrane antigen protein 1 in human erythrocyte-adapted P. knowlesi A1-H.1 strain","volume":"17","author":"Muh","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100613_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073530","article-title":"Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132","volume":"8","author":"Prasad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2025.100613_bib44","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1172\/JCI113766","article-title":"A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum","volume":"82","author":"Rosenthal","year":"1988","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijpddr.2025.100613_bib45","series-title":"A Practical Guide to the Histology of the Mouse","author":"Scudamore","year":"2014"},{"key":"10.1016\/j.ijpddr.2025.100613_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.ijpddr.2025.100613_bib47","article-title":"Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism","volume":"14","author":"Shafi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpddr.2025.100613_bib48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12936-019-3069-3","article-title":"Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies","volume":"18","author":"Souza","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100613_bib49","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2025.100613_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/a809656b","article-title":"A water-soluble tetrazolium salt useful for colorimetric cell viability assay","volume":"36","author":"Tominaga","year":"1999","journal-title":"Anal. Commun."},{"key":"10.1016\/j.ijpddr.2025.100613_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0020-7519(97)00080-5","article-title":"Continuous culture of Plasmodium falciparum: its impact on malaria research","volume":"27","author":"Trager","year":"1997","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100613_bib52","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100613_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12936-023-04766-1","article-title":"Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein","volume":"22","author":"Watson","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100613_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-198510030-00001","article-title":"Clinical pharmacokinetics of antimalarial drugs","volume":"10","author":"White","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpddr.2025.100613_bib55","series-title":"Strategy to Respond to Antimalarial Drug Resistance in Africa","year":"2022"},{"key":"10.1016\/j.ijpddr.2025.100613_bib56","series-title":"World Malaria Report","year":"2022"},{"key":"10.1016\/j.ijpddr.2025.100613_bib57","series-title":"WHO Guideline for Malaria","year":"2023"},{"key":"10.1016\/j.ijpddr.2025.100613_bib58","series-title":"World Malaria Report","year":"2024"},{"key":"10.1016\/j.ijpddr.2025.100613_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107213118","article-title":"Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome","volume":"118","author":"Xie","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ijpddr.2025.100613_bib60","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1002\/anie.202015845","article-title":"Development of a highly selective Plasmodium falciparum proteasome inhibitor with anti-malaria activity in humanized mice","volume":"60","author":"Zhan","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijpddr.2025.100613_bib61","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.jmedchem.2c01651","article-title":"Structure-Activity relationship studies of antimalarial plasmodium proteasome inhibitors\u2500part II","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100613_bib62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s42003-022-03215-0","article-title":"Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response","volume":"5","author":"Zhu","year":"2022","journal-title":"Commun. Biol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:25:50Z","timestamp":1772897150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320725000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"alternative-id":["S2211320725000363"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100613","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-targeting proteasome inhibitor ONX-0914 demonstrates potent antiplasmodial activity for malaria treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100613"}}